Spinal Stabilization Technologies™ Announces Enrollment of First U.S. Patient in IDE Trial for PerQdisc™ Nucleus Replacement Device
OrthoSpineNews
MARCH 3, 2025
based trial to evaluate its PerQdisc system for patients suffering from degenerative disc disease (DDD). For more information, visit: [link] SOURCE Spinal Stabilization Technologies patient in its Investigational Device Exemption (IDE) clinical trial for the PerQdisc Nucleus Replacement Device (NRD).
Let's personalize your content